These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 29096857

  • 1. ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
    Rodionov RN, Heinrich A, Brilloff S, Jarzebska N, Martens-Lobenhoffer J, Bode-Böger SM, Todorov VT, Hugo CPM, Weiss N, Hohenstein B.
    Atheroscler Suppl; 2017 Nov; 30():319-325. PubMed ID: 29096857
    [Abstract] [Full Text] [Related]

  • 2. ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
    Rodionov RN, Jarzebska N, Schneider A, Rexin A, Sradnick J, Brilloff S, Martens-Lobenhoffer J, Bode-Böger SM, Todorov V, Hugo C, Weiss N, Hohenstein B.
    Atheroscler Suppl; 2019 Dec; 40():100-105. PubMed ID: 31818438
    [Abstract] [Full Text] [Related]

  • 3. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD, Gao T, Stanley K, Cooper TK, Morris SM, Awad AS.
    Am J Physiol Renal Physiol; 2020 Feb 01; 318(2):F509-F517. PubMed ID: 31904280
    [Abstract] [Full Text] [Related]

  • 4. Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.
    Shi L, Zhao C, Wang H, Lei T, Liu S, Cao J, Lu Z.
    Antioxid Redox Signal; 2017 Dec 01; 27(16):1347-1360. PubMed ID: 28594240
    [Abstract] [Full Text] [Related]

  • 5. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V, Tomandl J, Pácal L, Klepárník M, Malúšková D, Bartáková V, Kuricová K, Rehořová J, Stěpánková S, Svojanovský J, Olšovský J, Bělobrádková J, Krusová D, Jurajda M, Mužík J, Pavlík T, Kaňková K.
    Kidney Blood Press Res; 2012 Dec 01; 36(1):200-8. PubMed ID: 23147199
    [Abstract] [Full Text] [Related]

  • 6. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H, Gao T, Raup-Konsavage WM, Cooper TK, Bronson SK, Reeves WB, Awad AS.
    Kidney Int; 2017 Mar 01; 91(3):671-682. PubMed ID: 27914709
    [Abstract] [Full Text] [Related]

  • 7. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.
    Diabetes Care; 2004 Mar 01; 27(3):765-9. PubMed ID: 14988299
    [Abstract] [Full Text] [Related]

  • 8. Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury.
    Jayachandran I, Sundararajan S, Paramasivam P, Venkatesan B, Subramanian SC, Balasubramanyam M, Mohan V, Manickam N.
    Clin Biochem; 2017 Oct 01; 50(15):835-842. PubMed ID: 28495185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.
    Tomlinson JA, Caplin B, Boruc O, Bruce-Cobbold C, Cutillas P, Dormann D, Faull P, Grossman RC, Khadayate S, Mas VR, Nitsch DD, Wang Z, Norman JT, Wilcox CS, Wheeler DC, Leiper J.
    J Am Soc Nephrol; 2015 Dec 01; 26(12):3045-59. PubMed ID: 25855779
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M, Paco-Meza LM, Ortega R, Cañadillas S, Caballero-Villarraso J, Blanco A, Herrera C.
    Pathol Res Pract; 2022 Feb 01; 230():153756. PubMed ID: 35032832
    [Abstract] [Full Text] [Related]

  • 15. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
    Nephrol Dial Transplant; 2009 Apr 01; 24(4):1162-9. PubMed ID: 19015171
    [Abstract] [Full Text] [Related]

  • 16. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.
    Awad AS, You H, Gao T, Cooper TK, Nedospasov SA, Vacher J, Wilkinson PF, Farrell FX, Brian Reeves W.
    Kidney Int; 2015 Oct 01; 88(4):722-33. PubMed ID: 26061548
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X, Zhang P, Kwak D, Fassett J, Yue W, Atzler D, Hu X, Liu X, Wang H, Lu Z, Guo H, Schwedhelm E, Böger RH, Chen P, Chen Y.
    Basic Res Cardiol; 2017 Aug 17; 112(5):55. PubMed ID: 28819685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.